Relationship between estrogen receptor-α polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women

References

• Koh K K. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res 2002; 55: 714–726
   PubMed Web of Science ®Google Scholar
• Schuit S C, Oei H H, Witteman J C, Geurts van Kessel C H, van Meurs J B, Nijhuis R L, van Leeuwen J P, de Jong F H, Zillikens M C, Hofman A, et al. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. J Am Med Assoc 2004; 291: 2969–2977
   PubMed Web of Science ®Google Scholar
• Nordström P, Glader C A, Dahlén G, Slunga Birgander L, Lorentzon R, Waldenström A, Lorentzon M. Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 2003; 254: 140–146
   PubMed Web of Science ®Google Scholar
• Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M, Mabuchi H. Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 817–823
   PubMed Web of Science ®Google Scholar
• Herrington D M, Howard T D, Brosnihan K B, McDonnell D P, Li X, Hawkins G A, Reboussin D M, Xu J, Zheng S L, Meyers D A, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879–1882
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Koh K K, Han S H, Quon M J. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005; 46: 1978–1985
   PubMed Web of Science ®Google Scholar
• Hillis G S. Soluble integrin adhesion receptors and atherosclerosis: much heat and a little light?. J Hum Hypertens 2003; 17: 449–453
   PubMed Web of Science ®Google Scholar
• Hou Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 2001; 173: 35–43
   PubMedGoogle Scholar
• Clearfield M B. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 2005; 105: 409–416
   PubMedGoogle Scholar
• McQuillan B M, Beilby J P, Nidorf M, Thompson P L, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999; 99: 2383–2388
   PubMed Web of Science ®Google Scholar
• Castro R, Rivera I, Blom H J, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006; 29: 3–20
   PubMed Web of Science ®Google Scholar
• Shearman A M, Cooper J A, Kotwinski P J, Miller G J, Humphries S E, Ardlie K G, Jordan B, Irenze K, Lunetta K L, Schuit S C, et al. Estrogen receptor α gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res 2006; 98: 590–592
   PubMed Web of Science ®Google Scholar
• Lawlor D A, Timpson N, Ebrahim S, Day I N, Smith G D. The association of oestrogen receptor α-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. Eur Heart J 2006; 27: 1597–1604
   PubMed Web of Science ®Google Scholar
• Koch W, Hoppmann P, Pfeufer A, Mueller J C, Schomig A, Kastrati A. No replication of association between estrogen receptor α gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation 2005; 112: 2138–2142
   PubMed Web of Science ®Google Scholar
• Nakai K, Itoh C, Kawazoe K, Miura Y, Sotoyanagi H, Hotta K, Itoh T, Kamata J, Hiramori K. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 1995; 6: 497–502
   PubMed Web of Science ®Google Scholar
• Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 7: 505–512
   Google Scholar
• Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri A M, Alexopoulos E, Memmos D. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113–119
   PubMed Web of Science ®Google Scholar
• De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2646–2654
   PubMed Web of Science ®Google Scholar
• Rohde L E, Lee R T, Rivero J, Jamacochian M, Arroyo L H, Briggs W, Rifai N, Libby P, Creager M A, Ridker P M. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1765–1770
   PubMed Web of Science ®Google Scholar
• Blann A D, McCollum C N. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151–154
   PubMed Web of Science ®Google Scholar
• Hwang S J, Ballantyne C M, Sharrett A R, Smith L C, Davis C E, Gotto A M, Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219–4225
   PubMed Web of Science ®Google Scholar
• Tzoulaki I, Murray G D, Lee A J, Rumley A, Lowe G D, Fowkes F G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112: 976–983
   PubMed Web of Science ®Google Scholar
• Pradhan A D, Rifai N, Ridker P M. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002; 106: 820–825
   PubMed Web of Science ®Google Scholar
• de Lemos J A, Hennekens C H, Ridker P M. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol 2000; 36: 423–426
   PubMed Web of Science ®Google Scholar
• Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001; 358: 971–976
   PubMed Web of Science ®Google Scholar
• Wallen N H, Held C, Rehnqvist N, Hjemdahl P. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J 1999; 20: 1039–1043
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht H J, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336–1342
   PubMed Web of Science ®Google Scholar
• Ghaisas N K, Shahi C N, Foley B, Goggins M, Crean P, Kelly A, Kelleher D, Walsh M. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol 1997; 80: 617–619
   PubMed Web of Science ®Google Scholar
• Mulvihill N T, Foley J B, Murphy R T, Curtin R, Crean P A, Walsh M. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart 2001; 85: 623–627
   PubMed Web of Science ®Google Scholar
• Guray U, Erbay A R, Guray Y, Yilmaz M B, Boyaci A A, Sasmaz H, Korkmaz S, Kutuk E. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 2004; 96: 235–240
   PubMed Web of Science ®Google Scholar
• Chou E T, Schulman S P, Thiemann D R, Sohn R H, Bellantoni M F, Rade J J. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris. Am J Cardiol 2003; 91: 1240–1242
   PubMed Web of Science ®Google Scholar
• Koh K K, Bui M N, Mincemoyer R, Cannon R O, 3rd. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. Am J Cardiol 1997; 80: 1505–1507
   PubMed Web of Science ®Google Scholar
• Van Baal W M, Emeis J J, Kenemans P, Kessel H, Peters-Muller E R, Schalkwijk C G, van der Mooren M J, Stehouwer C D. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 1999; 29: 913–921
   PubMed Web of Science ®Google Scholar
• Zanger D, Yang B K, Ardans J, Waclawiw M A, Csako G, Wahl L M, Cannon R O, 3rd. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 2000; 36: 1797–1802
   PubMed Web of Science ®Google Scholar
• Angerer P, Stork S, Kothny W, von Schacky C. Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries. Maturitas 2002; 41: 51–60
   PubMed Web of Science ®Google Scholar
• Goudev A, Georgiev D B, Koycheva N, Manasiev N, Kyurkchiev S. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas 2002; 30: 49–53
   Google Scholar
• Hemelaar M, van der Mooren M J, van Baal W M, Schalkwijk C G, Kenemans P, Stehouwer C D. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women. Menopause 2005; 12: 526–535
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Ohyama Y, Takahashi T, Saito Y, Nakamura T, Kanda T, Kurabayashi M. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. Am J Cardiol 2005; 96: 148–153
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Kasama S, Kumakura H, Takayama Y, Sakamaki T, Kurabayashi M. Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Hypertens Res 2005; 28: 579–584
   PubMed Web of Science ®Google Scholar
• Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani A R, Liao J K, De Caterina R. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 2000; 87: 19–25
   PubMed Web of Science ®Google Scholar
• Caulin-Glaser T, Watson C A, Pardi R, Bender J R. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996; 98: 36–42
   PubMed Web of Science ®Google Scholar
• Cid M C, Kleinman H K, Grant D S, Schnaper H W, Fauci A S, Hoffman G S. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type. J Clin Invest 1994; 93: 17–25
   PubMed Web of Science ®Google Scholar
• Aziz K E, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by β-estradiol, progesterone, and dexamethasone. Cell Immunol 1996; 167: 79–85
   PubMed Web of Science ®Google Scholar
• Collins T, Cybulsky M I. NF-κB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 2001; 107: 255–264
   PubMed Web of Science ®Google Scholar
• Harnish D C, Scicchitano M S, Adelman S J, Lyttle C R, Karathanasis S K. The role of CBP in estrogen receptor cross-talk with nuclear factor-κB in HepG2 cells. Endocrinology 2000; 14: 3403–3411
   Google Scholar
• Lakoski S G, Herrington D M. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article. Climacteric 2005; 8: 317–326
   PubMed Web of Science ®Google Scholar
• Dimitrowa K R, DeGroot K, Myers A K, Kim Y D. Estrogen and homocysteine. Cardiovasc Res 2002; 53: 577–588
   PubMed Web of Science ®Google Scholar
• Morris M S, Jacques P F, Selhub J, Rosenberg I H. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 152: 140–148
   PubMed Web of Science ®Google Scholar
• Reimann M, Vafeiadou K, Hall W L, Dierkes J, Nilsson M, Dahlman-Wright K, Ferrari M, Huebner U, Hallund J, Bugel S, et al. Evidence for associations between common polymorphisms of estrogen receptor β gene with homocysteine and nitric oxide. Climacteric 2006; 9: 215–223
   PubMed Web of Science ®Google Scholar